KOREAN
Company
Business
R & D
Investors
Company Overview
Welcome Message
Vision & Mission
History
C.I
Careers
Contact Us
Umbilical Cord Blood-derived Stem Cell
Stem Cell Therapy
Stem Cell Conditioned Media
Stem Cell Culture Media
Cell Freezing and Thawing Platform
CDMO
Health & Beauty(H&B) Business
Core Technology
Global R&D Center
Stem Cell GMP Center
Pipeline
Notice
IR
PR
Investors
Notice
IR
Disclosure Information
Stock Information
IR Resource Center
IR Letter & FAQ
PR
Press Release
PR Resource Center
Press Release
Investors
PR
Press Release
한국경제 인터뷰, 강경선 강스템바이오텍 의장 "제대혈 줄기세포로 아토피 근본적 치료 가능"
2017/07/05 10:22:12
[한국경제]
http://news.hankyung.com/article/2017070282501
목록으로
[제약바이오] 기피 대상에서 블루오션으로 200조원 희귀의약품 시장을 잡아라 - 조선비즈
줄기세포 치료제 시장 급성장, 기술력 인정받는 메디포스트 강스템바이오텍
About Us
Stock Information
Careers
Contact Us
Global R&D Center
Stem Cell GMP Center
Pipeline
TOP
pr : ir_news : view : : /pr/ir_news/view